Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Stop Big Pharma Profiteering

EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies

Read, watch, share

Letter |
14 September 2016
Research and development
European Union

Open letter to the European Commission

4 min
Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries. Photograph by Siddharth Singh
Press release
Press release |
29 March 2016
Intellectual property and trade
European UnionIndia

At EU-India Summit, India must defend its ‘pharmacy of the developing world’

PEP Drugs for children at Angau Memorial General Hospital, Lae/ Morobe Province in Papua New Guinea. The MSF Family Support Centre provides medical and psychological services for survivors of child abuse, sexual and intimate partner violence. MSF started providing care at the centre in November 2007. Photograph by Fiona Morris
Press release
Press release |
18 January 2016
Intellectual property and trade
European UnionIndia

As EU-India free trade talks get closer to resuming, MSF warns access to medicines under threat

A patient with TB shows the pills for his treatment in a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. MSF has been running a TB treatment program within the penitentiary system in Donetsk since 2011. Photograph by Manu Brabo
Press release
Press release |
14 October 2015
Intellectual property and trade
European Union

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’

3 min
A patient with TB shows the pills for his treatment in a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. MSF has been running a TB treatment program within the penitentiary system in Donetsk since 2011. Photograph by Manu Brabo
Press release
Press release |
12 October 2015
Intellectual property and trade
CanadaEuropean UnionAustralia

Access to affordable generic medicines for world’s poorest countries under threat

3 min
A man holds antiretroviral drugs at an activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015 Photograph by Stefan Heunis
Press release
Press release |
31 March 2015
Tuberculosis
LatviaEuropean Union

As first EU Ministerial meeting on tuberculosis closes, MSF calls on the EU to triple funding for TB R&D

3 min
MSF staff conducts a medical consultation with a female MDR-TB patient at MSF’s Insein Prison clinic, Yangon, Myanmar. Photograph by Aye Pyae Sone
Press release
Press release |
24 March 2015
Tuberculosis
European Union

MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week

3 min
Beat the Bulldozers: Separating fake from life-saving generic medicines
Feature story
Feature story |
18 December 2014
Research and development
European Union

Protecting Generic Medicines in Transit Through the EU

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury